These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1245 related articles for article (PubMed ID: 11062605)

  • 1. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
    Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
    Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis.
    Cunnane G; FitzGerald O; Hummel KM; Youssef PP; Gay RE; Gay S; Bresnihan B
    Arthritis Rheum; 2001 Aug; 44(8):1744-53. PubMed ID: 11508424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
    Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
    Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
    Katrib A; Smith MD; Ahern MJ; Slavotinek J; Stafford L; Cuello C; Bertouch JV; McNeil HP; Youssef PP
    J Rheumatol; 2003 Jan; 30(1):10-21. PubMed ID: 12508384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
    Kane D; Jensen LE; Grehan S; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2004 Jul; 31(7):1274-80. PubMed ID: 15229943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
    Giannelli G; Erriquez R; Iannone F; Marinosci F; Lapadula G; Antonaci S
    Clin Exp Rheumatol; 2004; 22(3):335-8. PubMed ID: 15144129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium.
    Kolb C; Mauch S; Krawinkel U; Sedlacek R
    Exp Cell Res; 1999 Jul; 250(1):122-30. PubMed ID: 10388526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above.
    Konttinen YT; Ceponis A; Takagi M; Ainola M; Sorsa T; Sutinen M; Salo T; Ma J; Santavirta S; Seiki M
    Matrix Biol; 1998 Dec; 17(8-9):585-601. PubMed ID: 9923652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
    Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
    Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.